Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Teva Announces Webcast on Results from Phase III ALLEGRO Study of Oral Laquinimod in Multiple Sclerosis
Pharmiweb
Saturday, April 9, 2011 - 11:48am
tags:
Teva Pharmaceuticals, multiple sclerosis
GSK Named As Bidder In Emerging Market Acquisition
Pharmaceutical Insight
Saturday, April 9, 2011 - 11:47am
tags:
GSK, Biofarma
OctoPlus Announces Agreement With Top-10 Biopharmaceutical Company
PR-USA.net
Saturday, April 9, 2011 - 11:42am
tags:
OctoPlus, drug delivery
China making big gains in drug R&D jobs state covets
Indianapolis Business Journal, IN
Saturday, April 9, 2011 - 11:41am
tags:
R&D, China
Hagens Berman Applauds $2 Million Verdict in Accutane Lawsuit
PR NewsWire
Saturday, April 9, 2011 - 11:39am
tags:
Accutane, Roche
Antares Pharma Inc. (AIS) Gets New Drug Application Approval from FDA
Favstocks
Saturday, April 9, 2011 - 11:38am
tags:
Antares, overactive bladder, Anturol
Calif. officials seek lower prices for AIDS drugs
Yahoo/AP
Saturday, April 9, 2011 - 11:16am
tags:
HIV
Don’t Talk to Me About Financials, Says Novartis R&D Head.
WSJ
Saturday, April 9, 2011 - 11:15am
tags:
Novartis, R&D
SuperGen: Merger Is A Step In The Right Direction
Seeking Alpha
Saturday, April 9, 2011 - 11:14am
tags:
Supergen
Big Celera shareholders line up against Quest acquisition
bizjournals.com
Saturday, April 9, 2011 - 11:13am
tags:
Quest, Celera
Johnson & Johnson Unit Settles U.K. Bribe Case for $7.9 Million
Bloomberg
Saturday, April 9, 2011 - 11:09am
tags:
JNJ, legal
Sunesis Signs Deal, Improves Pipeline Prospects
Seeking Alpha
Saturday, April 9, 2011 - 11:07am
tags:
Sunesis, vosaroxin, pan-Raf kinase inhibitors
MannKind Provides Regulatory Update
Yahoo/BusinessWire
Saturday, April 9, 2011 - 11:05am
tags:
MannKind
Sanofi-Aventis completes buyout of Genzyme
Yahoo/AP
Saturday, April 9, 2011 - 11:04am
tags:
Sanofi, Genzyme
Celgene Settles with Elan
Yahoo/Zacks
Saturday, April 9, 2011 - 11:03am
tags:
Celgene, Elan
Top 15 Most Undervalued Biotech Stocks By Analyst Target Price
Seeking Alpha
Saturday, April 9, 2011 - 11:02am
tags:
Prolor, Lexicon Pharmaceuticals, Dendreon, Human Genome Sciences, Targacept, Sequenom, Cadence Pharmaceuticals, Savient, ONYX Pharmaceuticals, Amylin, Emergent BioSolutions, XenoPort, Spectrum Pharmaceuticals, Incyte, Amgen
Amgen Expanding Into Brazil
Seeking Alpha
Saturday, April 9, 2011 - 10:58am
tags:
Amgen
Cephalon Wins Order in Patent Suit Delaying Sales of Generic Form of Amrix
Bloomberg
Saturday, April 9, 2011 - 10:57am
tags:
Cephalon, generics, Amrix, Impax Laboratories
ImmunoGen's Hot Start
Motley Fool
Saturday, April 9, 2011 - 10:56am
tags:
Immunogen, T-DM1, breast cancer, Herceptin, trastuzumab
StemCells shelves Batten disease program — not enough patients for trial
bizjournals.com
Saturday, April 9, 2011 - 10:55am
tags:
StemCells, Batten disease

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.